Cefoxitin Injection, Powder, For Solution
Product Images NDC 25021-110

4 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cefoxitin (NDC 25021-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cef0d 0011 01)

Structural Formula (Cef0d 0011 01)
Chemical structure of cefoxitin showing its molecular framework, including a beta-lactam ring and side chains, with a molecular weight of 449.44.*
FDA Label Image

Creatinine Conversion Formula (Cef0d 0011 02)

Creatinine Conversion Formula (Cef0d 0011 02)
A drug facts or prescribing information text panel showing formula calculations for males and females involving weight, age, and serum creatinine levels, likely related to dosing or pharmacokinetics. The scientific notation and variables are clearly displayed, but no product-specific branding is present.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cef0d 0011 03)

Package Label – Principal Display Panel – Vial Label (Cef0d 0011 03)
Label for Cefoxitin Injection, USP 1 gram per vial, powder for solution intended for intravenous use. The single-dose vial is labeled for sterile, nonpyrogenic, preservative-free cefoxitin sodium. The label includes manufacturer information for Sagent Pharmaceuticals, Schaumburg, IL, and states the product is made in Italy. Usage and storage instructions are also visible.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cef0d 0011 04)

Package Label – Principal Display Panel – Vial Label (Cef0d 0011 04)
Cefoxitin 2 grams per vial injection powder for solution label by Sagent Pharmaceuticals. The label indicates the product is for intravenous use only, single-dose vial. It includes storage instructions and highlights the sterile, nonpyrogenic nature of the product with no preservative.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.